The Medical Advisory Team (MAT) Vaccine Safety and Efficacy Work group has revised its recommendation to include additional guidance on the management of vaccine supply, including the full use of multi-dose vial contents that may contain more than 5 doses per vial. The MAT has reviewed the relevant documents related to the Pfizer-BioNTech COVID-19 vaccine as provided by the manufacturer, the U.S. Food and Drug Administration (FDA), and the U.S. Centers for Disease Control and Prevention (CDC) and concurs with the conclusions that the vaccine may prevent serious or life-threatening disease and that the known and potential benefits of the product outweigh the known and potential risks of the product. Therefore, the MAT recommends:
1. For those individuals who elect to receive a vaccine, approved healthcare providers in NM should administer the Pfizer-BioNTech COVID-19 vaccine consistent with the Emergency Use Authorization issued by the FDA and the clinical guidance provided by the CDC.
2. Approved healthcare providers in NM who administer the Pfizer-BioNTech COVID-19 vaccine should ensure each potential vaccine recipient receives the required vaccine information sheet to allow for a well-informed decision and receives the required vaccination documentation card upon vaccination.
